Login / Signup

Modification of allergen subcutaneous immunotherapy safety precautions and systemic allergic reaction rate reduction.

Keren Mahlab-GuriDavid MishayevMarina YakovlevIlan AsherZev SthoegerAlex GuriDaniel ElbirtShay NemetShira Rosenberg-Bezalel
Published in: Immunotherapy (2023)
Background: Despite their life-threatening potential, medical team mistakes during subcutaneous immunotherapy are rarely discussed. Real data are missing, and a survey study estimated that dosing errors are responsible for 25% of systemic reactions during immunotherapy. To minimize errors, we modified our safety precautions and compared the rates of systemic allergic reactions before and after the change. Methods: Our retrospective comparative cohort study compared systemic allergic reaction rates during 2012-2015 and 2016-2019, after a second check of the injected allergen/s by another nurse/physician was added to the treatment protocol. Results: The rate of systemic allergic reaction per injection was reduced from 0.93 to 0.71%; p = 0.023. Conclusion: A second check prior to injection is beneficial and can reduce the allergic reaction rate during immunotherapy.
Keyphrases
  • allergic rhinitis
  • primary care
  • randomized controlled trial
  • healthcare
  • emergency department
  • patient safety
  • atopic dermatitis
  • palliative care
  • cross sectional
  • machine learning
  • quality improvement